Oral antiseptics in the reduction of viral load of SARS-COV-2 in dental consultation
Keywords:
COVID-19, Mouthwashes, Dentistry, Saliva, Antivir.Abstract
The increase in COVID-19 infections worldwide and the susceptibility of the dental professionals due to close contact with patients' saliva and the production of aerosols carrying SARS-CoV-2, has generated the search for new preventive measures with the intention of reducing the risk present in the dental office. Recent research, based on the antiviral activity of some oral antiseptics, such as: chlorhexidine, povidone iodide, cetylpyridinium chloride and hydrogen peroxide; have focused on evaluating the efficacy that these different solutions might have against the new virus in media similar to the oral cavity. Based on this, this article has the objective of conducting a review on the antiviral efficacy of mouth rinses on SARS-CoV-2 as a preventive measure against the risk of transmission in the dental office. A search was made for original articles relevant to the topic, the databases were Medline and Scopus; electronic libraries: SciELO, WILEY, and academic search engines such as Google Scholar. In terms of results, iodopovidone has been shown to be more effective against COVID-19 followed by hydrogen peroxide, cetylpyridinium chloride and chlorhexidine. While clinical studies regarding the duration of efficacy in the oral cavity are limited, it was concluded that mouthwashes appear to be a good preventive, safe and a complementary option in dental practice; while awaiting more effective therapies or a vaccine.
Downloads
References
World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. 2020.
O’Donnell V, Thomas D, Stanton R, Maillard J, Murphy R, Jones S, et al. Potential Role of Oral Rinses Targeting the Viral Lipid Envelope in SARS-CoV-2 Infection. Funct. 2020;1(1): zqaa002.
Moosavi M S, Aminishakib, P, & Ansari M. Antiviral mouthwashes: possible benefit for COVID-19 with evidence-based approach. J. Oral Microbiol. 2020; 12(1):1794363
Peng, X, Xu X, Li Y, Cheng L, Zhou X, & Ren B. Transmission routes of 2019-nCoV and controls in dental practice. Int. J. Oral Sci. 2020; 12(1): 1-6.
Yoon JG, Yoon J, Song JY, Yoon SY, Lim CS, Seong H, Noh JY, Cheong HJ, Kim WJ. Clinical Significance of a High SARS-CoV-2 Viral Load in the Saliva. J Korean Med Sci. 2020;35(20):p.195.
Galo J. Estructura y composición del SARS-COV-2. Fundación Benalm. 2020; 30: 4-7.
Clementini M, Raspini M, Barbato L, Bernardelli F, Braga G, et al. Aerosol transmission for SARS‐CoV‐2 in the dental practice. A review by SIdP Covid‐19 task‐force. Oral Dis. 2020 oct 29. doi: 10.1111/odi.13649.
Seneviratne CJ, Balan P, Kwan Ki KK, Udawatte NS, Lai D, et al. Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore. Infect. 2020 Dec 14:1–7. doi: 10.1007/s15010-020-01563-9.
Meister T, Brüggemann Y, Conzelmann D, et al. Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2, J. Infect. Dis. 2020; 222 (15): 1289–1292
Kaur I, Sharma A, Deepak J, Das A, Sacchidanand S, Sharma R, et al. Coronavirus disease (COVID‐19): An updated review based on current knowledge and existing literature for dermatologists. Dermatol Ther. 2020; 33:e13677.
Schroter RC. Social distancing for covid-19: is 2 metres far enough? BMJ. 2020;369:m2010.
Ge ZY, Yang LM, Xia JJ, Fu XH, Zhang YZ. Possible aerosol transmission of COVID-19 and special precautions in dentistry. J Zhejiang Univ Sci B. 2020:1-8.
Xia J, Tong J, Liu M, Shen Y, Guo, D. (2020). Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS‐CoV‐2 infection. J Med Virol. 2020; (92): 589– 594.
Dadlani S. SARS-CoV-2 Transmission in a Dental Practice in Spain: After the Outbreak. Int Dent J, 2020; vol. 2020 Article ID 8828616.
Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020; 104: 246-251.
Aldahlawi S y Afifi I. COVID-19 in Dental Practice: Transmission Risk, Infection Control Challenge, and Clinical Implications. Open Dent J. 2020;14: 348 – 354.
James R, Mani A. Aerosoles dentales: un peligro silencioso en odontología. Int J Sci Res (Ahmedabad) 2016; 5 (11): 1761-3.
Raj G, Suma BS, Mangal G. Aerosol y salpicaduras dentales: un peligro silencioso e implicación en el control de infecciones en odontología. Eur J Pharm Med Res 2019; 6 (2): 603-7.
World Health Organization. Questions and Answers About Coronavirus Disease (COVID-19). 2020.
Carraturo F, Del Giudice C, Morelli M, Cerullo V, Libralato G, Galdiero E, et al. Persistence of SARS-CoV-2 in the environment and COVID-19 transmission risk from environmental matrices and surfaces. Environ Pollut. 2020; 265: 115010.
Challacombe S, Kirk-Bayley J., Sunkaraneni V. et al. Povidona yodada. Br Dent J. 2020; 228: 656–657.
Río-Carbajo L y Vidal P. Tipos de antisépticos, presentaciones y normas de uso. Medicina Intensiva, 2020;43 (S1): 7-12.
Carrouel F, Gonçalves LS, Conte MP, et al. Antiviral Activity of Reagents in Mouth Rinses against SARS-CoV-2. J Dent Res.2020; 100(2): 124–132.
Lepelletier D, Maillard JY, Pozzetto B, Simon A. Povidone Iodine: Properties, Mechanisms of Action, and Role in Infection Control and Decolonization. Antimicrob Agents Chemother. 2020; 64(9):e00682-20.
Herrera D, Serrano J, Roldán S. et al. Is the oral cavity relevant in SARS-CoV-2 pandemic?. Clin Oral Invest. 2020; 24: 2925–2930.
Bidra, AS, Pelletier, JS, Westover, JB, Frank S, Brown SM and Tessema B .Rapid In‐Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) Using Povidone‐Iodine Oral
Antiseptic Rinse. J Prosthodont. 2020; 29: 529-533.
Pelletier JS, Tessema B, Frank S, Westover JB, Brown SM, Capriotti JA. Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2). Ear Nose Throat J. 2020 Apr;100(2_suppl):192S-196S.
Anderson DE, Sivalingam V, Kang A E Z. et al. Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease. Infect Dis Ther, 2020; 9: 669–675.
Kalsi, H., Edwards, D. PVP-I mouth rinse in dental practice. Br Dent J, 2020: 229, 736.
Hassandarvish P, Tiong V, Mohamed N, et al. In vitro virucidal activity of povidone iodine gargle and mouthwash against SARS-CoV-2: implications for dental practice. Br Dent J; 2020 dec 10:1-4.
Frank S, Brown SM, Capriotti JA, Westover JB, Pelletier JS, Tessema B. Eficacia in vitro de un antiséptico nasal de povidona yodada para la inactivación rápida del SARS-CoV-2. JAMA Otolaryngol Head Neck Surg. 2020; 146 (11): 1054–1058.
Khan MM, Parab SR and Mandar P. Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic. Am J Otolaryngol. 2020;41(5):102618.
Bo Liang, Xudong Y, Gang W. In-Vivo Toxicity Studies and In-Vitro Inactivation of SARS-CoV-2 by Povidone-iodine In-situ Gel Forming Formulations. bioRxiv. 2020 May 20:2020.05.18.103184.
Martínez L, Diz P, Pérez MT, et al. Is povidone iodine mouthwash effective against SARS‐CoV‐2? First in vivo tests. Oral Dis. 2020 Jul 2:10.1111/odi.13526. doi: 10.1111/odi.13526.
Vergara A y Castro C. The Use of Mouthwashes against COVID-19 in Dentistry. Br J Oral Maxillofac Surg. 2020; 58 (8): 924–927.
National Health Commission of the ROC. Guide for the diagnosis and treatment of pneumonia caused by the new coronavirus. Pekín: National Health Commission of the ROC. 2020.
Statkute E, Rubina A, O’Donnell V, Thomas D, Stanton R. Brief Report: The Virucidal Efficacy of Oral Rinse Components Against SARS-CoV-2 In Vitro. BioRxiv. 2020; 11(13): 1-10.
Xu C, Wang A, Hoskin E, Cugini C, Markowitz K, Chang T, et al. Differential effects of antiseptic mouth rinses on SARS-CoV-2 infectivity in vitro. BioRxiv. 2020; 12(1): 1-33.
Roncal RJ, Tay-Chu-Jon LY. Aclaramiento Dental con Enjuagues de Libre Venta que Contienen Peróxido de Hidrógeno. Int. J. Odontostomat. 2018; 12(2):121-124.
Rashed HT. Evaluation of the effect of hydrogen peroxide as a mouthwash in comparison with chlorhexidine in chronic periodontitis patients: A clinical study. J Int Soc Prev Community Dent. 2016;6(3):206-212.
Mentel' R, Shirrmakher R, Kevich A, Dreĭzin RS, Shmidt I. Virus inactivation by hydrogen peroxide. Voprosy Virusologii. 1977; (6):731-733.
Capetti AF, Borgonovo F, Morena V, Lupo A, Cossu MV, Passerini M, et al. Short‐term inhibition of SARS‐CoV‐2 by hydrogen peroxide in persistent nasopharyngeal carriers. J Med Virol. 2021;93(3):1766-69.
Gottsauner MJ, Michaelides I, Schmidt B, Scholz KJ, Buchalla W, Widbiller M, et al. A
prospective clinical pilot study on the effects of a hydrogen peroxide mouthrinse on the intraoral viral load of SARS-CoV-2. Clin Oral Invest. 2020; (24): 3707–3713.
Bidra AS, Pelletier JS, Westover, JB, Frank S, Brown SM, Tessema B. Comparison of In Vitro Inactivation of SARS CoV‐2 with Hydrogen Peroxide and Povidone‐Iodine Oral Antiseptic Rinses. J Prosthodont. 2020; (29): 599-603.
Walsh LJ. Safety issues relating to the use of hydrogen peroxide in dentistry. Aust Dent J.2000; (45): 257-269.
Muñoz J, Perez D, León R, Blanc V, Gispert J, Clotet B, et al. Cetylpyridinium chloride-containing mouthwashes reduce in vitro SARS-CoV-2 infectivity. BioRxiv. 2020; 12(21): 1-13.
Green A, Roberts G, Tobery T, Vincent C, Barili M, Jones C. In vitro assessment of the virucidal activity of four mouthwashes containing Cetylpyridinium Chloride, ethanol, zinc and a mix of enzyme and proteins against a human coronavirus. BioRxiv. 2020; 10(28): 1-6.
Downloads
Published
Issue
Section
License
- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) posterior al proceso de aprobación del manuscrito, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada.
